Literature DB >> 31526985

Glycyrrhizin protects IGFBP-3 knockout mice from retinal damage.

Li Liu1, Youde Jiang1, Jena J Steinle2.   

Abstract

We previously reported that insulin-like growth factor binding protein 3 (IGFBP-3) knockout (KO) mice have neuronal and vascular damage to the retina. We also reported that glycyrrhizin, a high mobility growth factor binding protein 1 (HMGB1) inhibitor, is protective to the diabetic retina. In this study, we investigated whether glycyrrhizin could reduce neuronal and vascular damage in the IGFBP-3 KO mouse retina. We used measurements of retinal thickness, cell number in the ganglion cell layer, degenerate capillaries, reactive oxygen species (ROS) and protein levels of HMGB1, tumor necrosis factor alpha (TNFα), interleukin-1-beta (IL-1β) and sirtuin 1 (SIRT1) to determine whether glycyrrhizin could protect the retina. Data show that glycyrrhizin in the drinking water was effective in reducing neuronal damage at 2 months and vascular damage at 6 months. Glycyrrhizin reduced ROS levels at 6 months, and reduced levels of HMGB1, TNFα, and IL-1β at both 2 and 6 months. Taken together, the data suggest that glycyrrhizin is protective to the retina of IGFBP-3 KO mice through anti-inflammatory mechanisms.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiinflammatory; HMGB1; IGFBP-3; Mouse; Neuronal; Retina; Vascular

Mesh:

Substances:

Year:  2019        PMID: 31526985      PMCID: PMC6875639          DOI: 10.1016/j.cyto.2019.154856

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  21 in total

1.  IGFBPs modulate IGF-I- and high glucose-controlled growth of human retinal endothelial cells.

Authors:  S Giannini; B Cresci; L Pala; A Ciucci; A Franchini; C Manuelli; Y Fujita-Yamaguchi; P Cappugi; R Zonefrati; C M Rotella
Journal:  J Endocrinol       Date:  2001-11       Impact factor: 4.286

2.  IGFBP3 promotes esophageal cancer growth by suppressing oxidative stress in hypoxic tumor microenvironment.

Authors:  Mitsuteru Natsuizaka; Hideaki Kinugasa; Shingo Kagawa; Kelly A Whelan; Seiji Naganuma; Harry Subramanian; Sanders Chang; Kei J Nakagawa; Naryan L Rustgi; Yoshiaki Kita; Shoji Natsugoe; Devraj Basu; Phyllis A Gimotty; Andres J Klein-Szanto; J Alan Diehl; Hiroshi Nakagawa
Journal:  Am J Cancer Res       Date:  2014-01-15       Impact factor: 6.166

3.  Increased basement membrane thickness, pericyte ghosts, and loss of retinal thickness and cells in dopamine beta hydroxylase knockout mice.

Authors:  Jena J Steinle; Timothy S Kern; Steven A Thomas; Lisa S McFadyen-Ketchum; Christopher P Smith
Journal:  Exp Eye Res       Date:  2009-01-07       Impact factor: 3.467

4.  IGFBP-3 inhibits TNF-α production and TNFR-2 signaling to protect against retinal endothelial cell apoptosis.

Authors:  Qiuhua Zhang; Jena J Steinle
Journal:  Microvasc Res       Date:  2014-07-30       Impact factor: 3.514

5.  IGFBP-3 and TNF-α regulate retinal endothelial cell apoptosis.

Authors:  Qiuhua Zhang; Youde Jiang; Matthew J Miller; Bonnie Peng; Li Liu; Carl Soderland; Jie Tang; Timothy S Kern; John Pintar; Jena J Steinle
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-09       Impact factor: 4.799

6.  IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development.

Authors:  Kyung-Hee Chang; Tailoi Chan-Ling; Evan L McFarland; Aqeela Afzal; Hao Pan; Louise C Baxter; Lynn C Shaw; Sergio Caballero; Nilanjana Sengupta; Sergio Li Calzi; Sean M Sullivan; Maria B Grant
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-13       Impact factor: 11.205

7.  IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.

Authors:  Chatarina Lofqvist; Jing Chen; Kip M Connor; Alexandra C H Smith; Christopher M Aderman; Nan Liu; John E Pintar; Thomas Ludwig; Ann Hellstrom; Lois E H Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-13       Impact factor: 11.205

8.  Epac1 deacetylates HMGB1 through increased IGFBP-3 and SIRT1 levels in the retinal vasculature.

Authors:  Youde Jiang; Li Liu; Jena J Steinle
Journal:  Mol Vis       Date:  2018-11-16       Impact factor: 2.367

9.  Glycyrrhizin Protects the Diabetic Retina against Permeability, Neuronal, and Vascular Damage through Anti-Inflammatory Mechanisms.

Authors:  Li Liu; Youde Jiang; Jena J Steinle
Journal:  J Clin Med       Date:  2019-07-02       Impact factor: 4.241

10.  β-Adrenergic receptor agonist, compound 49b, inhibits TLR4 signaling pathway in diabetic retina.

Authors:  Elizabeth A Berger; Thomas W Carion; Youde Jiang; Li Liu; Adam Chahine; Robert Jason Walker; Jena J Steinle
Journal:  Immunol Cell Biol       Date:  2016-02-18       Impact factor: 5.126

View more
  2 in total

Review 1.  Inherited Retinal Dystrophies: Role of Oxidative Stress and Inflammation in Their Physiopathology and Therapeutic Implications.

Authors:  Isabel Pinilla; Victoria Maneu; Laura Campello; Laura Fernández-Sánchez; Natalia Martínez-Gil; Oksana Kutsyr; Xavier Sánchez-Sáez; Carla Sánchez-Castillo; Pedro Lax; Nicolás Cuenca
Journal:  Antioxidants (Basel)       Date:  2022-05-30

Review 2.  The Roles of Insulin-Like Growth Factor Binding Protein Family in Development and Diseases.

Authors:  Fei Song; Xiao-Xia Zhou; Yu Hu; Gang Li; Yan Wang
Journal:  Adv Ther       Date:  2020-12-17       Impact factor: 3.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.